Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

ABSTRACT: To evaluate the clinical efficacy and safety of hypofractionation radiotherapy combined with sintilimab，GM-CSF and Fruquintinib in Patients With MSS Metastatic Colorectal Carcinoma (mCRC)

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2710363 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR